Hello, welcome to Bioperfectus
For A Healthier Life
Dedicated to human health with a network covering more than 50 countries and regions.
A public listed company specialized in diagnostic solution of infectious diseases and many others.
Nucleic Acid Extraction Solution -
to ensure a consolidated start for PCR
BioPerfectus, a public listed company at Shanghai Stock Exchange (SSE:688399), is one of the leading molecular diagnostic solution providers in global in-vitro diagnostic market since 2010.
One of the leading molecular diagnostic solution providers in global in-vitro diagnostic market since 2010.
Bioperfectus is key real-time PCR product supplier for Chinese disease prevention and control market.
Company news and information of Jiangsu Bioperfectus Technology Co. Ltd..
Reach out to us and explore more of bioPerfectus.
We, bioperfectus, are glad to inform that Novel Corona Virus (SARS-CoV-2) Ag Rapid Test Kit already passed...
Ebola, one of the most fatal viruses that has ever recorded in human civilization resurged in Guinea and Congo in February of 2021.
To meet with various testing demands in different clinical laboratories, Bioperfectus Novel Corona Virus (SARS-CoV-2) Ag Rapid Test...
Copyright © 2010-2021 Jiangsu Bioperfectus Technologies Co., Ltd All Rights Reserved.